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In 2003, expenditure on diabetes, the fourth leading cause of death in Taiwan, consumed more than US$320 million. 1 Improvement in the quality of diabetes care is critical, both for the sake of patients and to lower healthcare costs. However, previous studies have suggested poor adherence to practice standards, unsatisfactory glycemic control and a high prevalence of diabetic complications in Taiwan. [2] [3] [4] Nonadherence and poor glycemic control could be related to patient-, provider-or healthcare system-based issues. 5 Different service provisions by generalists and specialists could result in variations in the quality of diabetes care. Several studies have shown better processes of care, superior glycemic control, and better cost-effectiveness or fewer complications in diabetes care provided by diabetes specialists. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] However, other studies reported no meaningful differences in outcomes of diabetes care provided by different physician specialists. 12, 16, 17 Comparisons of the quality of diabetes care provided by different specialty groups could have been influenced by patient characteristics, physician factors, organizational variations or insuranceprogram differences. Unlike most other countries, the National Health Insurance (NHI) program enrolls 96% of people and contracts 93.8% of the medical institutions in Taiwan. 18 This unique comprehensive nationwide medical insurance program minimizes barriers to medical care. With accreditation as one of the leading centers for clinical service, teaching and research, the quality of diabetes care at National Taiwan University Hospital (NTUH) is expected to be of a high standard in Taiwan. 19 Since neither the NHI nor the NTUH sets regulations for diabetes care referral, patients can freely access physicians of different specialties according to their own preference. At NTUH, the majority of diabetes patients are under the care of endocrinologists (EN), other specialists in internal medicine (internists, IM) or family medicine physicians (generalists, FM). Whether or not physician specialty has an influence on the quality of diabetes care in such a medical center is an interesting topic. To our knowledge, no previous report has discussed the use of antidiabetes drugs in patients cared for by physicians of different specialties. This retrospective study was conducted to evaluate the influence of physician specialty on the use of antidiabetes medications. With consideration of patient casemix and physician characteristics, this study also evaluated the quality of diabetes care, both in terms of process and outcomes, provided by different physician specialists. LFT is now recommended as one necessary diabetes care measure in the NHI quality-based payment program. 21 We therefore included adherence to LFT as one indicator in our analysis. In this study, the process indicators were evaluated by counting the annual frequency of those diabetic care measures. Glucose measurement included either fasting plasma glucose (FPG) or postprandial plasma glucose (PPG). Self-monitored blood glucose was not included in this study. The lipid profile included total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). Urinalysis included urine routine and urine microalbumin. When more than one laboratory examination under the same category was performed during one OPD visit, the frequency of the examination in that category was counted only once. Adherence to the measures was considered to be positive when the examination was performed at least once within the year. The adherence to fundus examination or electrocardiogram was not assessed in this study. The outcome indicators included systolic blood pressure (SBP), diastolic blood pressure (DBP) and blood levels of HbA 1C , FPG, PPG, TC, TG, HDL-C and LDL-C. Blood pressure (BP) checkup did not include home monitoring. Serum FPG or PPG level was measured using the TBA-120FR analyzer (Toshiba Corp., Tokyo, Japan) with the HK-G6PD (hexokinase and glucose-6-phosphate dehydrogenase) method. HbA 1C was measured using the Primus CLC 385 (Primus Corp., Kansas City, MO, USA) with the high performance liquid chromatography method. Serum creatinine, serum ALT, TC, TG, HDL-C and LDL-C were measured using the TBA-200 autoanalyzer (Toshiba Corp.) with Jaffe's method, JSCC transferable method, enzymatic method, enzymatic-colorimetric method, direct and direct methods, respectively. Those intermediate outcomes were analyzed using the latest data in that year. Percentages of patients with their BP, glycemic or lipid control achieving recommendations 22 were also included as outcome indicators. In model 2, regression analysis was adjusted for the major care physician's sex and age. Both casemix and physician characteristics were considered in model 3. A p value of less than 0.05 was considered statistically significant.
Methods

Study design and population
Statistical analysis
Results
A total of 875 patients (477 men, 398 women) with a mean age of 62.3 ± 12.7 years (range, 19-100 years) were enrolled in this study. The mean duration of diabetes mellitus was 9.8 ± 6.6 years. The mean frequency of OPD visits during the year was 9.5 ± 4.2. The numbers of patients who were regularly treated by EN, IM and FM were 385, 320 and 170, respectively. Gender distribution and diabetes duration were not significantly different among EN, IM and FM groups. Patients in the EN group were younger. They had fewer comorbidities/complications, but more OPD visits than patients in the other two groups ( Table 1) . The mean serum creatinine levels for patients of EN, IM and FM were 1.1 ± 1.0 mg/dL (n = 170), 1.1 ± 1.0 mg/dL (n = 182) and 0.9 ± 0.3 mg/dL (n = 117), respectively. The mean serum ALT levels for patients of EN, IM and FM were 31.5 ± 35.3 U/L (n = 155), 38.4 ± 35.3 U/L (n = 147) and 32.5 ± 27.2 U/L (n = 100), respectively. Mean serum creatinine and ALT levels were not statistically different among the different patient groups.
There were 13 EN, 39 internists and 18 generalists enrolled in this study. The mean age of the major care physicians was 48.0 ± 8.1, 46.1 ± 7.7 and 42.0 ± 6.4 years for EN, IM and FM groups, respectively. The percentage of males in EN, IM and FM physicians was 97.5%, 96.9% and 82.3%, respectively.
About 29% of the patients were treated with a single oral hypoglycemic agent (OHA), 59.5% were treated with more than two classes of OHAs, 5.4% were treated with insulin alone and 6.1% were treated with a combination of OHA and insulin. For all patients, the maximum class-number of drugs had significant correlations with the levels of FPG, PPG and HbA 1C (r = 0.202, 0.166, 0.213, respectively, all p < 0.001). The correlations remained significant no matter whether it was the EN, IM or FM group. The mean class-numbers of antidiabetes drugs did not differ among the different patient groups. However, EN patients had the highest rate of being prescribed insulin, metformin, nonsulfonylurea insulin secretagogues and the lowest rate of being given sulfonylureas ( Table 2 ).
The adherence rates to annual measures for all the patients were as follows: glucose checkup 89.7%, HbA 1C measurement 82.5%, urinalysis 48%, RFT 53.6%, lipid profile 69% and LFT 45.9%. The EN group had the highest adherence to glucose checkup, HbA 1C measure and urinalysis, while patients in the FM group had the highest adherence to annual RFT, lipid profile and LFT (Table 3 ). The significance of the differences for the adherence between IM and EN groups and between FM and EN groups varied in different models of logistic regressions (Table 4) . However, the differences in adherence to glucose, HbA 1C tests and urinalysis between the IM and EN groups remained statistically significant regardless of adjustment for case-mix, physician characteristics or both. The EN group also had persistently significantly higher adherence to glucose checkup and urinalysis than the FM group (Table 4) .
Among those who had examinations within the study year, the EN group had the highest frequencies of glucose checkup, HbA 1C testing and urinalysis (Table 3 ). In the evaluation of the correlation between the process and the intermediate outcomes of diabetes care, we found that frequencies of glucose or HbA 1C testing had no correlation with FPG or HbA 1C levels, but more frequent glucose testing correlated with lower PPG levels (r = −0.16, p < 0.001).
Not all patients had body weight, body height or BP recorded in their medical charts. Body mass index (BMI) and BP measurement in the study year were available in 68.6% and 77.7%, 62.2% and 84.8%, and 76.5% and 90.8% of the EN, IM and FM patients, respectively. The mean levels of intermediate outcomes for all the patients with available data were as follows: BMI 25. had the lowest mean SBP (Table 5) . Following adjustment for case-mix and physician characteristics, the difference in SBP between groups became statistically nonsignificant. In linear regression analysis, EN patients had persistently significantly better FPG control when compared to FM patients regardless of adjustments for patient case-mix, physician characteristics or both. EN patients also had significantly better PPG control when compared to IM patients. The differences in serum HDL-C and LDL-C levels between the EN and FM groups were originally nonsignificant, but the differences became statistically significant in linear regression analysis with full model adjustment ( Table 6 ).
Discussion
Suboptimal accountability for diabetes care in Taiwan was first reported from a regional teaching hospital in 1996. 2 In that study, adherence rates to HbA 1C measure and urinalysis at diabetes patients' first visits were reported to be 40.9% and 57.5%, respectively. 2 About 9.9% and 18.6% of the diabetes patients never received any HbA 1C test or urinalysis during a follow-up period of 3 years. 2 Using year 2001 NHI Taipei Branch claims data, the annual adherence rates to glucose checkup, HbA 1C measure, urinalysis, RFT, lipid profile and LFT were reported to be 76.3%, 42.7%, 40.2%, 59.7%, 59.2% and 53.2%, respectively. 4 In October 2001, in a bid to improve the quality of diabetes care, the NHIB implemented the quality-based payment program for diabetes care. We did not evaluate the influence of that program because none of the studied patients were recruited into that program. The adherence rates to most of the diabetes care measures at NTUH were higher than those previously reported.
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The mean HbA 1C and FPG levels in this study were also lower than those of 25 diabetes centers in Taiwan. 3 However, a failure to meet the recommended standards, such as low adherence to urinalysis or missing records for body weight or BP measures, was still noted. Our findings suggest that there is a need to improve the quality of diabetes care. At NTUH, diabetes patients have free access to physicians for their diabetes care. Patients of internists usually have diseases other than diabetes. For convenience, most patients with other systemic diseases preferred to be cared for by internists for their major diseases and to get their antidiabetes drugs from the internists at the same time. Patients cared for by generalists usually had more, but relatively mild, diseases. The "cluster" effect of patients with specific characteristics to remain with physicians having specific characteristics has been discussed before. 17 In our series, EN patients were younger and had lower numbers of comorbidities/complications. This observation suggests that younger diabetes patients prefer to be cared for by EN. Trying to enroll patients with the same disease severity, we excluded patients who had visited emergency services or who had been admitted to hospital. The sex ratios, mean duration of diabetes, serum creatinine and ALT levels were not different among groups. To minimize possible bias originating from the heterogeneity of the patient population, we further adjusted patient characteristics in our analysis.
In reviewing antidiabetes prescription patterns, the tendency away from monotherapy with insulins or sulfonylureas and toward combination therapies has been reported in the US and in Stockholm. 24, 25 The use of OHAs other than sulfonylureas has increased rapidly. [24] [25] [26] It was reported that improvement in metabolic and 12 Generalists, who were female and younger, showed better performance than EN with regard to BP and body weight recording in this study. Pellegrini et al 29 reported a higher risk for poor BP control by male physicians and a lower risk for poor BP control by EN.
Other studies did not demonstrate the effects of physician specialties on BP control. 12, 16, 17 In our series, the FM group had the lowest SBP. However, the differences in BP control became insignificant after adjustment for case-mix and physician characteristics. This result suggests that there are no meaningful differences in BP control for diabetes patients under the care of physicians of different specialties. Berardis et al 10 reported better TC levels in patients cared for in diabetes OPD clinics. In our series, the differences in HDL-C and LDL-C between the EN and FM groups were originally nonsignificant, but the differences became statistically significant after full model adjustment. Since patient numbers with HDL-C and LDL-C available were small, we would like to be more cautious in making conclusions from these findings. Our study showed a significant effect of physician specialty on the process and the intermediate glycemic outcomes of diabetes care. However, this conclusion has several limitations. First, outcome data were not available for patients who did not receive examinations in the year. The analysis is thus limited by incomplete data in some patients. Second, not all indicators of glycemic control showed similar statistically significant results. Third, initial glycemic and BP levels were not extracted from medical records in this retrospective study. We therefore cannot estimate the real improvement in glycemic and BP control contributed by different physician specialties. Fourth, we did not assess and adjust for physician attitudes and beliefs. It has been reported that the personal attitudes and beliefs of the individual physician, rather than physician specialty or setting of care, influence metabolic control. 30 Fifth, we did not evaluate the influence of patients' socioeconomic status. Studies have reported that patients of lower socioeconomic standing are less likely to receive specialist care. 5 Lower socioeconomic status is also an important risk factor for nonutilization of preventive services. 5, 13, 31 Sixth, the adjustment with numbers of comorbidities/complications might not be enough to reflect the variation and complexity of patients' disease entities.
In conclusion, our analysis showed different use of antidiabetes drugs among patients cared for by EN, internists and generalists. Our findings highlight the effects of physician specialty on the process and outcomes of diabetes care. We suggest consistent education and further enhancement for improving the quality of diabetes care in Taiwan.
